Table 3 Information on the screened potential biomarkers through PLS-DA and ROC tests
From: Metabolomics analysis of visceral leishmaniasis based on urine of golden hamsters
Mode | Compound ID | Compound name | AUROC | Ionic strength changea | ||
|---|---|---|---|---|---|---|
4 WPI | 12 WPI | 4 WPI | 12 WPI | |||
ESI+ | 0.763_452.1177 | 3-Nitro-l-tyrosine | 0.84 | 0.89 | 3.52 | − 0.43 |
ESI+ | 3.558_234.1006 | Dl-5-Methoxytryptophan | 1 | 0.81 | 2.17 | 3.44 |
ESI+ | 3.595_203.0585 | 1-(2,4-Dihydroxyquinolin-3-yl)ethan-1-one | 1 | 1 | − 0.31 | 3.25 |
ESI+ | 4.248_220.085 | 5-Hydroxy-l-tryptophan | 0.91 | 0.86 | − 0.63 | 1.56 |
ESI+ | 4.591_187.1001 | 2-[(Dimethylamino)methylidene]indan-1-one | 0.94 | 1 | − 0.35 | 6.82 |
ESI+ | 4.593_189.1157 | N-Benzyl-4-piperidone | 0.97 | 1 | − 0.26 | 9.87 |
ESI− | 5.562_269.0724 | N-(1,1-Dioxothiolan-3-yl)-4-methoxybenzamide | 0.97 | 1 | − 0.32 | 6.84 |